Erratum: CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis (Theranostics (2021) 11:5 (2297-2317) DOI: 10.7150/thno.51000)

Wenzhi Shen*, Xiaoyuan Zhang, Jiaping Tang, Zhixin Zhang, Renle Du, Dehong Luo, Xiaoran Liu, Yong Xia, Yanping Li, Shanshan Wang, Siyuan Yan, Wancai Yang, Rong Xiang, Na Luo, Yunping Luo, Jianjun Li

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

In our article [1], there were misplaced images in Figure 7E and Figure 8D, respectively. The corrected version is provided here. (Figure Presented) The correction made in this erratum does not affect the original conclusions. The authors apologize for any inconvenience or misunderstanding that this error may have caused.

Original languageEnglish
Pages (from-to)7128-7129
Number of pages2
JournalTheranostics
Volume11
Issue number14
DOIs
Publication statusPublished - 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Erratum: CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis (Theranostics (2021) 11:5 (2297-2317) DOI: 10.7150/thno.51000)'. Together they form a unique fingerprint.

Cite this